Antibody responses were detected in all vaccine recipients on day 239 (Figure 1A, upper panels). The median binding antibody titer against the WA1/2020 receptor-binding domain was 645 on day 29, 1772 ...
One can acquire humoral immunity to a specific infection or disease if administered with antibodies from someone who was previously been exposed to the same infection, circumventing the humoral ...
Chimeric antigen receptor T cell therapy reduces vaccine immunity, with many patients lacking seroprotection despite stable antibody levels.
In a recent study published in PLoS Pathogens, researchers explored probable humoral immune mechanisms related to Epstein-Barr virus (EBV) curtailment, besides neutralization, by a systematic emphasis ...
Randomized phase II study of olaparib with or without cediranib in men with metastatic castration-resistant prostate cancer (mCRPC). This is an ASCO Meeting Abstract from the 2020 Genitourinary ...
Prolonged Clinical and Molecular Remission in Patients With Low-Grade or Follicular Non-Hodgkin's Lymphoma Treated With Rituximab Plus CHOP Chemotherapy: 9-Year Follow-Up The unique immunoglobulin ...
Humoral immunity produces antigen-specific antibodies and is primarily driven by B cells. Cell-mediated immunity on the other hand does not depend on antibodies for its adaptive immune functions and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results